Warsaw, Poland

Hanna Fitek

This inventor holds 1 USPTO granted patent. Top assignee: Instytut Farmaceutyczny. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hanna Fitek. Retrieved from https://idiyas.com/inventor/hanna-fitek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hanna Fitek: Innovator in Pharmaceutical Chemistry

Introduction

Hanna Fitek is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of valuable compounds. Her innovative work has led to the development of new intermediates that are essential for creating pharmacologically active substances.

Latest Patents

Hanna Fitek holds a patent for the "Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds." This patent discloses a process for preparing 24-alkyl analogs of cholecalciferol, which have a (5E) or (5Z) configuration. The invention includes new intermediates and non-racemic compounds that serve as valuable synthones for the synthesis of pharmacologically active substances. She has 1 patent to her name.

Career Highlights

Hanna Fitek is associated with the Instytut Farmaceutyczny, where she has been instrumental in advancing research in pharmaceutical sciences. Her work has not only contributed to the academic community but has also had practical implications in the development of new medications.

Collaborations

Throughout her career, Hanna has collaborated with notable colleagues, including Andrzej Kutner and Jacek Martynow. These collaborations have enriched her research and expanded the impact of her innovations in the field.

Conclusion

Hanna Fitek is a remarkable inventor whose work in pharmaceutical chemistry continues to influence the development of new therapeutic agents. Her contributions are vital to the advancement of medical science and the creation of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…